Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Hyponatremia in a Patient With Cancer.

Uppal NN, Wanchoo R, Barnett R, Sinha A, Jhaveri KD.

Am J Kidney Dis. 2020 Jan;75(1):A15-A18. doi: 10.1053/j.ajkd.2019.09.005. No abstract available.

PMID:
31864502
2.

Selinexor for Refractory Multiple Myeloma.

Jhaveri KD, Wanchoo R.

N Engl J Med. 2019 Nov 14;381(20):1977. doi: 10.1056/NEJMc1912625. No abstract available.

PMID:
31722162
3.

Acute kidney injury in hematopoietic stem cell transplantation.

Wanchoo R, Stotter BR, Bayer RL, Jhaveri KD.

Curr Opin Crit Care. 2019 Dec;25(6):531-538. doi: 10.1097/MCC.0000000000000657.

PMID:
31524721
4.

Monoclonal gammopathy-associated thrombotic microangiopathy.

Yui JC, Garceau D, Jhaveri KD, Wanchoo R, Bijol V, Glezerman I, Hassoun H, Dispenzieri A, Russell SJ, Leung N.

Am J Hematol. 2019 Oct;94(10):E250-E253. doi: 10.1002/ajh.25569. Epub 2019 Jul 17. No abstract available.

PMID:
31257598
5.

Ibrutinib induced acute tubular injury: A case series and review of the literature.

Manohar S, Bansal A, Wanchoo R, Sakhiya V, Lucia S, Jhaveri KD.

Am J Hematol. 2019 May 31. doi: 10.1002/ajh.25546. [Epub ahead of print] No abstract available.

PMID:
31148235
6.

Adverse Events Associated With Immune Checkpoint Inhibitors.

Jhaveri KD, Wanchoo R.

JAMA. 2019 Mar 26;321(12):1218-1219. doi: 10.1001/jama.2018.22114. No abstract available.

PMID:
30912827
7.

Renal involvement in chronic lymphocytic leukemia.

Wanchoo R, Bernabe Ramirez C, Barrientos J, Jhaveri KD.

Clin Kidney J. 2018 Oct;11(5):670-680. doi: 10.1093/ckj/sfy026. Epub 2018 Apr 11.

8.

Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.

Wanchoo R, Bayer RL, Bassil C, Jhaveri KD.

Am J Kidney Dis. 2018 Dec;72(6):857-865. doi: 10.1053/j.ajkd.2018.06.013. Epub 2018 Aug 23. Review. Erratum in: Am J Kidney Dis. 2019 Feb;73(2):291.

PMID:
30146419
9.

Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologists.

Mallappallil MC, Fishbane S, Wanchoo R, Lerma E, Roche-Recinos A, Salifu M.

BMC Nephrol. 2018 Jun 22;19(1):147. doi: 10.1186/s12882-018-0943-0.

10.

Nephropathology Education During Nephrology Fellowship Training in the United States.

Mechery V, Hernandez T, Mathew AT, Wanchoo R, Seshan SV, Jhaveri KD, Shah HH.

Kidney Int Rep. 2017 Dec 22;3(2):236-241. doi: 10.1016/j.ekir.2017.11.014. eCollection 2018 Mar. No abstract available.

11.

Left Ventricular Assist Devices and the Kidney.

Ross DW, Stevens GR, Wanchoo R, Majure DT, Jauhar S, Fernandez HA, Merzkani M, Jhaveri KD.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):348-355. doi: 10.2215/CJN.04670417. Epub 2017 Oct 25. Review.

12.

Light chain Fanconi syndrome in a patient with acute myeloid leukemia and monoclonal gammopathy of undetermined significance.

Ross DW, Wanchoo R, Guigova A, Ghiuzeli C, Allen SL, Jhaveri KD.

CEN Case Rep. 2016 Nov;5(2):238-241. doi: 10.1007/s13730-016-0232-3. Epub 2016 Aug 30.

13.

Endovascular aneurysm repair (EVAR)- and transcatheter aortic valve replacement (TAVR)-associated acute kidney injury.

Jhaveri KD, Saratzis AN, Wanchoo R, Sarafidis PA.

Kidney Int. 2017 Jun;91(6):1312-1323. doi: 10.1016/j.kint.2016.11.030. Epub 2017 Mar 17. Review.

PMID:
28318632
14.

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.

Wanchoo R, Karam S, Uppal NN, Barta VS, Deray G, Devoe C, Launay-Vacher V, Jhaveri KD; Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors.

Am J Nephrol. 2017;45(2):160-169. doi: 10.1159/000455014. Epub 2017 Jan 12. Review.

15.

Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.

Wanchoo R, Abudayyeh A, Doshi M, Edeani A, Glezerman IG, Monga D, Rosner M, Jhaveri KD.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):176-189. doi: 10.2215/CJN.06100616. Epub 2016 Sep 21. Review.

16.

Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review.

Jhaveri KD, Wanchoo R, Sakhiya V, Ross DW, Fishbane S.

Kidney Int Rep. 2016 Sep 21;2(1):108-123. doi: 10.1016/j.ekir.2016.09.055. eCollection 2017 Jan. Review.

17.

Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System.

Jhaveri KD, Sakhiya V, Wanchoo R, Ross D, Fishbane S.

Kidney Int. 2016 Sep;90(3):706-7. doi: 10.1016/j.kint.2016.06.027. No abstract available.

PMID:
27521117
18.

Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network.

Wanchoo R, Jhaveri KD, Deray G, Launay-Vacher V.

Clin Kidney J. 2016 Apr;9(2):245-51. doi: 10.1093/ckj/sfv149. Epub 2016 Jan 18. Review.

19.

BRAF inhibitors - do we need to worry about kidney injury?

Wanchoo R, Devoe C, Jhaveri KD.

Expert Opin Drug Saf. 2016 May;15(5):579-81. doi: 10.1517/14740338.2016.1164139. Epub 2016 Mar 22. No abstract available.

PMID:
26954036
20.

Harvoni (Ledipasvir With Sofosbuvir)-Induced Renal Injury.

Wanchoo R, Thakkar J, Schwartz D, Jhaveri KD.

Am J Gastroenterol. 2016 Jan;111(1):148-9. doi: 10.1038/ajg.2015.391. No abstract available.

PMID:
26785666
21.

Update on the End-Stage Renal Disease Quality Incentive Program.

Wanchoo R, Hazzan AD, Fishbane S.

Semin Dial. 2016 Mar-Apr;29(2):144-7. doi: 10.1111/sdi.12463. Epub 2016 Jan 12.

PMID:
26756666
22.

Onconephrology abstracts and publication trends: time to collaborate.

Thakkar J, Wanchoo R, Jhaveri KD.

Clin Kidney J. 2015 Oct;8(5):629-31. doi: 10.1093/ckj/sfv085. Epub 2015 Sep 24.

23.

Nephrology Crosswords: Diabetic nephropathy.

Wanchoo R, Jhaveri KD.

Kidney Int. 2015 Sep;88(3):647-8. doi: 10.1038/ki.2015.8. No abstract available.

24.

Carfilzomib-induced nephrotoxcity.

Jhaveri KD, Wanchoo R.

Kidney Int. 2015 Jul;88(1):199-200. doi: 10.1038/ki.2015.133. No abstract available.

25.

The need for enhanced training in nephrology medical education research.

Jhaveri KD, Wanchoo R, Maursetter L, Shah HH.

Am J Kidney Dis. 2015 May;65(5):807-8. doi: 10.1053/j.ajkd.2015.01.011. Epub 2015 Feb 21. No abstract available.

PMID:
25708554
26.

A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use.

Baird P, Leung S, Hoang H, Babalola O, Devoe CE, Wanchoo R, Jhaveri KD.

J Oncol Pharm Pract. 2016 Apr;22(2):357-60. doi: 10.1177/1078155214568581. Epub 2015 Jan 14.

PMID:
25591868
27.

Intravenous iron exposure and outcomes in patients on hemodialysis.

Fishbane S, Mathew AT, Wanchoo R.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1837-9. doi: 10.2215/CJN.09510914. Epub 2014 Oct 15. No abstract available.

28.

Carfilzomib-related acute kidney injury may be prevented by N-acetyl-L-cysteine.

Wanchoo R, Khan S, Kolitz JE, Jhaveri KD.

J Oncol Pharm Pract. 2015 Aug;21(4):313-6. doi: 10.1177/1078155214531804. Epub 2014 Apr 18.

PMID:
24748581
29.

Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.

Hazzan AD, Shah HH, Hong S, Sakhiya V, Wanchoo R, Fishbane S.

Kidney Int. 2014 Jul;86(1):34-9. doi: 10.1038/ki.2013.528. Epub 2014 Jan 8. Review.

30.

Difference in central and peripheral recovery in a patient with severe axonal motor neuropathy and central nervous system involvement and review of literature.

Moody SB, Wanchoo RJ, Kalamangalam GP, Infante E, Sheikh KA.

J Clin Neuromuscul Dis. 2013 Mar;14(3):110-3. doi: 10.1097/CND.0b013e3182852542. Review.

32.

Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants.

Weng FL, Patel AM, Wanchoo R, Brahmbhatt Y, Ribeiro K, Uknis ME, Mulgaonkar S, Mathis AS.

Transplantation. 2007 Feb 15;83(3):290-6.

PMID:
17297403

Supplemental Content

Loading ...
Support Center